Skip to main content
Signal8
Katz Michael David M.D. profile photo

Michael David Katz M.D.

CIK: 0001919798

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Hanover Bancorp, Inc. /MD logo
HNVR

Hanover Bancorp, Inc. /MD

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Hanover Bancorp, Inc. /MD logo
    HNVR

    Hanover Bancorp, Inc. /MD

    Feb 5, 2026
    Award(A)
    Direct
    1.6K shares-
  • Hanover Bancorp, Inc. /NY logo
    HNVR

    Hanover Bancorp, Inc. /NY

    Jan 29, 2025
    Award(A)
    Direct
    1.3K shares-
  • Hanover Bancorp, Inc. /NY logo
    HNVR

    Hanover Bancorp, Inc. /NY

    Dec 10, 2024
    Sale(S)
    Direct
    5K shares at avg. $25.53$128K

1-3 of 3

About Katz Michael David M.D.

Katz Michael David M.D. (SEC CIK 0001919798) files insider reports with the SEC as Director of Hanover Bancorp, Inc. /MD (HNVR).

Signal8 holds 3 ownership filings by Katz Michael David M.D., all Form 4s, filed between Dec 11, 2024 and Feb 9, 2026. Those filings report 3 transactions, from Dec 10, 2024 to Feb 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Katz Michael David M.D.'s filings is in MINEOLA, NY.

Recent filings by Katz Michael David M.D.

  • Feb 5, 2026: Grant or award of HNVR shares (Form 4, code A).
  • Jan 29, 2025: Grant or award of HNVR shares (Form 4, code A).
  • Dec 10, 2024: Open-market sale of HNVR shares (Form 4, code S).

Other insiders filing for Hanover Bancorp, Inc. /MD (HNVR)

How to read Form 4 transaction codes